BridgeBio Advances ATTR-CM Treatment through the drug

Researchers have substantially boosted its development of an new treatment for ATTR-CM, leveraging the investigational drug. Preliminary patient data suggests promising outcomes for patients diagnosed by this debilitating disease. This focus highlights researchers’ commitment to managing critical medical requirements in a heart disease arena. At

read more